Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer
{{output}}
Background: Hereditary leiomyomatosis and renal-cell cancer (HLRCC) is an inherited disorder characterized by germline pathogenic variants in the gene encoding fumarate hydratase and an increased risk of papillary renal-cell carc... ...
